Why these 4 ASX shares have started the week with a bang

The Bendigo and Adelaide Bank Ltd (ASX:BEN) share price is one of four starting the week strongly. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The benchmark S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has defied international markets and pushed higher on Monday. In early afternoon trade the benchmark index is up 0.3% to 5,887.7 points.

Four shares that have climbed more than most today are listed below. Here's why they have started the week with a bang:

The Bendigo and Adelaide Bank Ltd (ASX: BEN) share price has risen 5% to $10.39 following the release of a positive broker note out of Goldman Sachs. According to the note, Goldman has upgraded the regional bank's shares from a neutral rating to a buy rating. The broker made the change as it believes Bendigo and Adelaide Bank has strong leverage to recent and future deposit margin improvement and has the most immediate leverage in the sector to a rising cash rate environment.

The Newcrest Mining Limited (ASX: NCM) share price is up 2.5% to $20.50 after the gold miner received approval from the NSW Department of Planning and Environment to use the first 200 metres of the old Cadia Hill open pit as a tailings storage facility. Newcrest is now installing the pipeline infrastructure, with utilisation of the open pit as a storage facility expected to commence in the first week of May.

The Western Areas Ltd (ASX: WSA) share price has pushed a further 3% higher to $3.82. This leading nickel miner's shares have been on fire this month thanks to rising nickel prices. There are concerns that potential U.S. sanctions could hit a leading Russian nickel producer and global supplies hard.

The Zelda Therapeutics Ltd (ASX: ZLD) share price is up 4.5% to 11.5 cents. This morning the cannabis-based biotechnology company advised that recruitment for Australia's first clinical study of medical cannabis to treat insomnia is now complete. The company's study will soon begin, with patients undergoing baseline sleep measurements before commencing pharmaceutical dosing. Results are due out by the end of the year and will be worth watching out for.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »